Abacus Planning Group, Inc. Viatris Inc Transaction History

Abacus Planning Group, Inc.

$552 Million
Q4 2024

A detailed history of Abacus Planning Group, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 22,884 shares of VTRS stock, worth $199,319. This represents 0.05% of its overall portfolio holdings.

Number of Shares

22,884

Previous 18,916 20.98%

Holding current value

$199,319

Previous $219,000 29.68%

% of portfolio

0.05%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$11.32 - $13.37 $44,917 - $53,052	3,968 Added 20.98%	22,884 $284,000
Q3 2024 Oct 02, 2024	SELL	$10.32 - $12.13 $183,592 - $215,792	-17,790 Reduced 48.47%	18,916 $219,000
Q2 2024 Jul 30, 2024	BUY	$10.05 - $12.02 $34,662 - $41,456	3,449 Added 10.37%	36,706 $390,000
Q1 2024 Apr 11, 2024	BUY	$11.27 - $13.53 $137,854 - $165,498	12,232 Added 58.18%	33,257 $397,000
Q4 2023 Jan 19, 2024	SELL	$8.77 - $10.85 $375,399 - $464,434	-42,805 Reduced 67.06%	21,025 $227,000
Q3 2023 Oct 11, 2023	BUY	$9.59 - $11.35 $44,641 - $52,834	4,655 Added 7.87%	63,830 $629,000
Q2 2023 Jul 06, 2023	SELL	$9.02 - $10.29 $56,573 - $64,538	-6,272 Reduced 9.58%	59,175 $590,000
Q1 2023 Apr 17, 2023	BUY	$9.2 - $12.26 $421,470 - $561,655	45,812 Added 233.32%	65,447 $629,000
Q4 2022 Jan 19, 2023	BUY	$8.72 - $11.56 $171,217 - $226,980	19,635 New	19,635 $0
Q2 2022 Jul 18, 2022	BUY	$9.95 - $12.27 $194,005 - $239,240	19,498 New	19,498 $204,000
Q1 2021 Apr 27, 2021	SELL	$13.59 - $18.54 $287,279 - $391,917	-21,139 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$14.3 - $18.74 $302,287 - $396,144	21,139 New	21,139 $396,000

Others Institutions Holding VTRS

# of Institutions

1,142

Shares Held

988M

Call Options Held

2.34M

Put Options Held

2.21M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $10.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.

Account

Abacus Planning Group, Inc. Viatris Inc Transaction History